2019 Mar – 2023 Feb | $7.64M

Clinical evaluation of AntimalarialS tri-therapy with AtovAquone-Proguanil for treatment of uncomplicated malaria in African children (ASAAP) European & Developing Countries Clinical Trials Partnership (EDCTP), Kwame Nkrumah University of Science and Technology, Kumasi, Ghana | Oumou Maiga-Ascofare | Gabon, Benin, Burkina Faso, Guinea, Mali

Similar Posts

  • 2019 Jan – 2020 Dec

    Ex-vivo clinical candidate drug assay against field clinical isolated blood stages parasites of P. malariae and P. ovale using 10 compounds from MMV. Medicines for Malaria Venture (MMV), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Laurent Dembele | Ghana, Mali

  • DELGEME

    The Developing Excellence in Leadership and Genetics Training for Malaria Elimination in sub-Saharan Africa (DELGEME) is a training programme sponsored by the Wellcome Trust Developing Excellence in Leadership, Training and Science Africa (DELTAS Africa) initiative in partnership with the Department of International Development (DFID) and the Alliance for Accelerating Excellence in Science in Africa (AESA). …

  • PfTBV-Consortuim

    Assessing safety, efficacy and transmission blocking properties of the new anti-malarial KAF156 combined with a new formulation of lumefantrine in children and adults with uncomplicated Plasmodium sp. malaria in West and Central Africa (WANECAM II) European & Developing Countries Clinical Trials Partnership (EDCTP), University of Sciences, Techniques and Technologies of Bamako (USTTB), Mali | Abdoulaye…

Leave a Reply

Your email address will not be published. Required fields are marked *